Pulmonx Corporation LUNG
2.72 USD +0.14 (+5.43%)
At closeNov 3, 2026, 4:00 PM EST
2.70 -0.02 -0.74%
After hours · Nov 3, 4:00 PM ET
2.58 Day range 2.78
1.13 52-week range 3.25
- YTD
- +23.08%
- 1 year
- +48.63%
Analyst view
Consensus: buy
Buy
Price target (mean) 11.92 +338.1% upside
Now 2.72
- Target (low)
- 7.50
- Target (mean)
- 11.92
- Target (high)
- 16.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
- Strong buy1
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.44894 | -0.47 – -0.41 | -0.36 | -24.7% | 22.29M | +15.6% | 5 |
| Next quarter | -0.39623 | -0.45 – -0.35 | -0.36 | -10.1% | 22.23M | +17.9% | 5 |
| Current year | -1.56 | -1.58 – -1.52 | -1.60 | +2.5% | 82.32M | +19.9% | 5 |
| Next year | -1.58 | -1.81 – -1.43 | -1.56 | -1.3% | 97.72M | +18.7% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 11, 2024 | Citigroup | Downgrade | Buy | Neutral |
| Oct 31, 2024 | Stifel | Maintained | Buy | Buy |
| Aug 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 1, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 1, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 4, 2024 | Lake Street | Initiated | — | Buy |
| May 2, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 3, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 23, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 23, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Feb 22, 2024 | Stifel | Maintained | Buy | Buy |
| Feb 22, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 22, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 31, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 31, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 5, 2023 | Craig-Hallum | Initiated | — | Buy |
| Aug 3, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 11, 2023 | Citigroup | Maintained | Buy | Buy |
| May 3, 2023 | Citigroup | Maintained | — | Buy |
| May 3, 2023 | Piper Sandler | Maintained | — | Overweight |
| May 3, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Apr 3, 2023 | Citigroup | Maintained | — | Buy |
| Feb 27, 2023 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Feb 24, 2023 | Citigroup | Maintained | — | Buy |
| Feb 23, 2023 | Canaccord Genuity | Maintained | — | Buy |
| Feb 23, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 6, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 3, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Dec 12, 2022 | Wells Fargo | Maintained | — | Equal-Weight |